Biotec Services expands with new appointments

November 7, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotec services

Clinical trials services firm Biotec Services International is expanding its presence in the US and the UK with three new …

£10 million boost for synthetic biology

November 6, 2013
Research and Development, Sales and Marketing Biological, Synthetic, biotech

The Biotechnology and Biological Science Research Council (BBSRC) has put up £10 million which can be accessed by small companies …

Deepak Khanna image

PPRS to remain in UK, but drug growth curbed

November 6, 2013
Sales and Marketing ABPI, DH, Deepak Khanna, NHS, PPRS

The UK government has announced that the PPRS pricing scheme will largely remain intact, but will have a curb put …

Adheris image

inVentiv Health acquires Catalina Health

November 6, 2013
Medical Communications Adheris, catalina, inVentiv Health

Consulting and services company inVentiv Health has acquired a subsidiary of Catalina (Catalina Health) and joined it onto its own …

Roche image

ImmunoGen stops cancer trial

November 6, 2013
Research and Development, Sales and Marketing Cancer, IMGN901, Immunogen, Roche

Roche subsidiary ImmunoGen has abandoned a Phase II trial into small-cell lung cancer (SCLC) after deciding that it was not …

dan_bradbury

Profil Institute hires former Amylin chief executive

November 6, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amylin, profil institute

Clinical research firm Profil Institute has appointed former Amylin chief executive Dan Bradbury to its Board of directors.  “Dan Bradbury …

BIA image

UK is the go-to place for developing medicines

November 5, 2013
Research and Development, Sales and Marketing BIA, Cell Medica, ReNeuron, UK

The BioIndustry Association (BIA) has said that the UK is clearly the must-go-to location for regenerative medicine research and development. …

J&J image

J&J hit with $2.2 billion fine

November 5, 2013
Sales and Marketing J&J, JJ, Janssen, Risperdal, antipsychotic, fine

Johnson & Johnson has admitted promoting its big-selling antipsychotic drug Risperdal off-label, costing the firm $2.2 billion in fines. The …

BMS image

BMS files oral hep C treatment

November 5, 2013
Sales and Marketing BMS, HCV, dvc, hep C

Bristol-Myers Squibb has filed its investigational hepatitis C treatment – the first oral regime without interferon or ribavirin – with …

jeff_winton_astellas

Astellas poaches comms head from Lilly

November 5, 2013

Astellas has hired Jeffrey Winton from Eli Lilly to be its senior vice president and chief communications officer.Winton who will …

GSK image

GSK ‘may not face corporate charges’

November 5, 2013
Medical Communications, Sales and Marketing China, GSK, bribery

GlaxoSmithKline is unlikely to face a company-wide charge for corruption following investigations by authorities in China according to reports. The …

The Gateway to Local Adoption Series

Latest content